| Lorelie Bermejo Bada, MD | |
|
811 Northgate Blvd, New Albany, IN 47150-6419 | |
| (502) 287-4100 | |
| Not Available |
| Full Name | Lorelie Bermejo Bada |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Location | 811 Northgate Blvd, New Albany, Indiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508978628 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | KY 35144 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Lorelie Bermejo Bada, MD 3901 Zaring Mill Ct, Louisville, KY 40241-3035 Ph: () - | Lorelie Bermejo Bada, MD 811 Northgate Blvd, New Albany, IN 47150-6419 Ph: (502) 287-4100 |
News Archive
"This clinical trial proves beyond any doubt that inside the artery therapy is the best possible treatment for patients suffering an acute ischemic stroke from a large artery occlusion," according to Donald Frei, MD, Neuro Interventional Surgeon at Swedish Medical Center and Radiology Imaging Associates in Englewood, CO.
The Autism Speaks Autism Treatment Network (ATN), has received a $12 million federal grant to continue to serve as the Autism Intervention Research Network on Physical Health.
For more than 1 million people in the U.S. living with spinal cord injury, the frightening days and weeks following the injury are filled with uncertainty about their potential for recovery and future independence. A new model based on motor scores at admission and early imaging studies may allow clinicians to predict functional outcomes and guide decision-making for therapy and care-giving needs, as described in an article published in Journal of Neurotrauma, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
ARIAD Pharmaceuticals, Inc. today announced results of preclinical studies on ponatinib, its investigational pan-BCR-ABL inhibitor, showing potent inhibition of all four members of the fibroblast growth factor receptor (FGFR) family of tyrosine kinases that are abnormally expressed in multiple cancers. ARIAD scientists are presenting the data this morning at the American Association for Cancer Research (AACR) Annual Meeting in Orlando, Florida.
› Verified 3 days ago
Matthew David Mccollough, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2630 Grant Line Rd, New Albany, IN 47150 Phone: 812-945-0145 Fax: 812-949-5435 | |
Viktor Miro, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1850 State St, New Albany, IN 47150 Phone: 260-266-2020 Fax: 812-944-7701 | |
Syed T Raza, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1919 State Street, Suite 302, New Albany, IN 47150 Phone: 812-542-1880 Fax: 812-542-1891 | |
Mrs. Ifeoma Roseline Okeke, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2210 Green Valley Road, Floyd Memorial Cancer Center Of Indiana, New Albany, IN 47150 Phone: 812-945-4000 Fax: 812-941-5714 | |
Mahesh K Jindal, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4101 Technology Ave, New Albany, IN 47150 Phone: 812-941-4500 | |
Dr. Hrak Chemchirian, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2109 Green Valley Rd, New Albany, IN 47150 Phone: 812-948-2232 | |
Carl Edward Dillman Jr., MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2109 Green Valley Rd, New Albany, IN 47150 Phone: 812-948-2232 Fax: 812-945-0869 |